Changes of NLF in Serum of Long COVID Patients
April 26, 2023 updated by: Laura de Boni, University Hospital, Bonn
The study investigates the blood NFL levels in Long-COVID patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study investigates the blood NFL levels in Long-COVID patients.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bonn, Germany, 53105
- Laura de Boni
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Patients with Long-COVID-Syndrome
Description
Long-COVID Syndrom
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
LONGCOVID
Patient with Long-COVID Syndrom
|
NFL measruments in serum
|
|
CONTROLS
Healthy individials
|
NFL measruments in serum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Levels of NFL over a 1 year course of the Long-COVID Syndrom
Time Frame: 1 year
|
see above
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
October 31, 2021
Study Completion (Actual)
November 1, 2021
Study Registration Dates
First Submitted
August 9, 2021
First Submitted That Met QC Criteria
September 27, 2021
First Posted (Actual)
September 29, 2021
Study Record Updates
Last Update Posted (Actual)
April 28, 2023
Last Update Submitted That Met QC Criteria
April 26, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 1 (Mobile Health and Wellness Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.